Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

HER2-NEGATIVE

Clinical trials for HER2-NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new HER2-NEGATIVE trials appear

Sign up with your email to follow new studies for HER2-NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1
Sort by
  • Triple-Drug cocktail shows promise for tough stomach cancer

    Disease control Ongoing

    This study tests whether combining an immunotherapy drug (nivolumab) with standard chemotherapy (FOLFOX) and a targeted therapy (regorafenib) can safely control HER2-negative metastatic esophagogastric cancer. About 39 adults with advanced cancer that has spread will receive the …

    Matched conditions: HER2-NEGATIVE

    Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

    Last updated Jun 27, 2026 09:10 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space